Gene therapy trial for Hunter syndrome to begin

iStock/Sasha_Suzi

A gene therapy trial for young children diagnosed with Hunter syndrome has been given the go ahead in the UK.

The combined phase 1 and 2 clinical trial by University of Manchester researchers, is now open to recruitment and up to five youngsters aged between three and 12 months with the rare lysosomal storage disorder will be treated with autologous hematopoietic stem cell gene therapy.